**Core Concept**
Pregnancy-associated breast cancer (PABC) is a rare condition, but its management is crucial due to the high risk of recurrence and the need to balance cancer treatment with fetal development. The management of PABC in the second trimester involves a multidisciplinary approach to ensure optimal outcomes for both the mother and the fetus.

**Why the Correct Answer is Right**
In the second trimester, the risk of miscarriage and fetal anomalies is lower, allowing for more aggressive cancer treatment. The management options for carcinoma breast in the second trimester include:

* **Option D:** Chemotherapy, which can be safely administered during the second trimester, with most chemotherapeutic agents having a low risk of teratogenicity.
* **Option D:** Surgery, including mastectomy or breast-conserving surgery, can be performed during the second trimester to remove the tumor and prevent recurrence.
* **Option D:** Hormonal therapy, such as tamoxifen or aromatase inhibitors, can be used to reduce the risk of recurrence and improve survival rates.

**Why Each Wrong Option is Incorrect**
**Option A:** Radiation therapy is generally avoided during pregnancy due to the risk of fetal harm and long-term developmental effects.

**Option B:** Stereotactic body radiation therapy (SBRT) is not typically used during pregnancy due to the high doses of radiation involved, which can increase the risk of fetal anomalies.

**Option C:** Proton beam radiation therapy (PBRT) is not commonly used during pregnancy due to the high cost and limited availability, as well as the risk of fetal exposure to radiation.

**Clinical Pearl / High-Yield Fact**
When managing PABC in the second trimester, it is essential to involve a multidisciplinary team of healthcare professionals, including oncologists, obstetricians, and radiologists, to ensure that the treatment plan balances the needs of both the mother and the fetus.

**Correct Answer:** D.